Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

491.809
-11.589-2.30%
Number of Gainers:7
Number of Losers:23
Number of Flat:3
PE:- -
High:505.901
Open:503.516
Low:489.571
Close:503.398
Volume:68.58M
Turnover:2.31B
Market Cap:314.14B
Float Cap:278.01B

Loading ...

Redefining Roles: Commercial Health Insurance Enters a New Era of Partnership in China's Next Five-Year Plan

Deep News
·
Aug 25

Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals

Stock News
·
Aug 25

ETF Market Daily: Healthcare Sector Shows Solid Valuations While Innovative Drug Subsegments See Dense Catalysts, Spotlight on Hang Seng Biotech ETF and STAR Innovative Drug ETF

Deep News
·
Aug 25

Jacobio Pharmaceuticals Group (SEHK:1167) Stock Repriced After Surprise Profit Swing

Simply Wall St.
·
Aug 25

Market Sees Gains Across More Than 4,200 Stocks as Innovative Drug Sector Surges and Gold Shares Slip | Huabao Fund 3A Daily Report (August 25, 2026)

Deep News
·
Aug 25

InnoCare Pharma (SEHK:9969) Stock Jumps As Profit Arrives And Pipeline Risk Persists

Simply Wall St.
·
Aug 25

ZYLOXTB Allocates HK$1.18 Million for Share Buyback on August 25

Stock News
·
Aug 25

Zylox-Tonbridge Files HKEX Next-Day Disclosure After Share Repurchase Cancellation

Reuters
·
Aug 25

TH MEDICAL-B Forges Strategic Alliance with Genertec Liaoning Pharmaceutical

Stock News
·
Aug 25

ETF Market Wrap (Aug 25): Interim Results Validate Innovative Drug Sector Rally While Gold's Pullback Caps Mining Stock Gains

Stock News
·
Aug 25

午后市场反弹,A股主要指数表现分化:农业和医药板块领涨,市场成交额达1.8万亿元

Deep News
·
Aug 25

A-share Market Close | Indices Diverge While Stocks Rise Broadly; Small Appliances, Pharma, and Agriculture Lead Gains, Precious Metals Decline

Stock News
·
Aug 25

Hong Kong Stock Alert | ALEBUND-B (09637) Surges Over 6% on Dual Catalysts of Index Inclusion and Earnings, with Mircera Commercialization Poised for Growth

Stock News
·
Aug 25

Sweden's Isofol Medical Reports no Q2 Revenue, Net Loss Widens

Reuters
·
Aug 25

Everest Med Surges Over 17% in Afternoon Trade as Core Drug Nefecon Drives Strong Revenue Growth

Deep News
·
Aug 25

Midday Market Snapshot: Hang Seng Index Slips 0.25% in Morning Session, Mainland Property Stocks Rally Broadly

Stock News
·
Aug 25

Interim Results Analysis: PEIJIA-B's Core AR Product Exceeds Expectations, Reinforcing Profitability Signals and Investment Certainty

Stock News
·
Aug 25

RemeGen Swings to Profit in H1 as Revenue Surges Fivefold

MT Newswires Live
·
Aug 25

Antengene Receives Clinical Trial Approval in Australia for Phase I Attract Study of Atg-201 (Cd19 X Cd3 Tce) in B Cell-Related Autoimmune Diseases

THOMSON REUTERS
·
Aug 25

Antengene's ATG-201 Phase I ATTRACT Trial Receives Australian Ethics Committee Approval for B-Cell Autoimmune Disease Therapy

Stock News
·
Aug 25